Literature DB >> 7530378

The dopamine-serotonin relationship in clozapine response.

S Szymanski1, J Lieberman, S Pollack, R Munne, A Safferman, J Kane, M Kronig, T Cooper.   

Abstract

The effects of clozapine on the dopamine and serotonin systems may underlie its atypical pharmacologic and clinical profile. To examine this hypothesis, we measured dopamine and serotonin plasma and cerebrospinal (CSF) metabolites and the relationship of these values to treatment response in 19 neuroleptic refractory and intolerant schizophrenic patients. Only a small change in the CSF and plasma homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) levels was found. However, the pretreatment CSF HVA/5HIAA ratio and, to a lesser extent, the CSF HVA level predicted treatment response. These results suggest that the modest relationship between HVA and 5-HIAA and treatment response supports the involvement of both neurotransmitters in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7530378     DOI: 10.1007/bf02245011

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.

Authors:  Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2002-07-05       Impact factor: 4.530

Review 2.  Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

Authors:  A Y Deutch; B Moghaddam; R B Innis; J H Krystal; G K Aghajanian; B S Bunney; D S Charney
Journal:  Schizophr Res       Date:  1991 Mar-Apr       Impact factor: 4.939

3.  Clozapine effects on tardive dyskinesia.

Authors:  J A Lieberman; B L Saltz; C A Johns; S Pollack; J M Kane
Journal:  Psychopharmacol Bull       Date:  1989

4.  Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography.

Authors:  C G Fri; F A Wiesel; G Sedvall
Journal:  Life Sci       Date:  1974-06-16       Impact factor: 5.037

5.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

6.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

Review 7.  Clozapine: new research on efficacy and mechanism of action.

Authors:  H Y Meltzer; B Bastani; L Ramirez; S Matsubara
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

8.  Effect of clozapine on 5-HIAA excretion in urine and CSF of psychotic patients and on serotonin metabolism in rat brain.

Authors:  M Ackenheil; B Blatt; C Lampart
Journal:  Acta Vitaminol Enzymol       Date:  1975

9.  Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

Authors:  D Pickar; R R Owen; R E Litman; E Konicki; R Gutierrez; M H Rapaport
Journal:  Arch Gen Psychiatry       Date:  1992-05

10.  Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

Authors:  H Agren; I N Mefford; M V Rudorfer; M Linnoila; W Z Potter
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

View more
  3 in total

Review 1.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

2.  Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationship.

Authors:  Farhat Batool; Muhammad A Haleem; Darakhshan J Haleem
Journal:  Sci Pharm       Date:  2009-11-29

3.  Biological Predictors of Clozapine Response: A Systematic Review.

Authors:  Ruta Samanaite; Amy Gillespie; Kyra-Verena Sendt; Grant McQueen; James H MacCabe; Alice Egerton
Journal:  Front Psychiatry       Date:  2018-07-26       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.